(Q37868973)

24 August 2017

1 reference

title

Gene therapy for mesothelioma (English)

1 reference

24 August 2017

0 references

Anil Vachani

1

1 reference

24 August 2017

Edmund Moon

series ordinal

2

1 reference

24 August 2017

Steven M Albelda

series ordinal

3

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Current Treatment Options in Oncology

24 August 2017

published in

1 reference

24 August 2017

volume

12

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

173-180

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-011-0153-5

24 August 2017

exact match

0 references

cites work

Safety and efficacy of gene transfer for Leber's congenital amaurosis

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Gene therapy of inherited diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Viral gene therapy strategies: from basic science to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Adenoviral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Lentiviral vectors for anti-tumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Clinical application of lentiviral vectors - concepts and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Gene therapy using adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Recombinant adeno-associated virus transduction and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Structure and function of lipid-DNA complexes for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Gene therapy progress and prospects: nonviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Gene-modified PA1-STK cells home to tumor sites in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Interferon beta adenoviral gene therapy in a patient with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Supernatural T cells: genetic modification of T cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Adoptive T cell therapy for cancer in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-011-0153-5

Use of suicide genes in gene therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21519819

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antiviral activity and mechanism of action of ganciclovir

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21519819

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cancer gene therapy with targeted adenoviruses

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21519819

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11864-011-0153-5

1 reference

24 August 2017

1 reference